Transcript Combination Products Overview
NCMD
Bringing Together North Carolina’s Medical Device Community
SBIR Seminar Introduction to NCMD
March 24, 2005 Andrew DiMeo North Carolina Medical Device Organization [email protected]
www.NCMedicalDevice.org
Phone: 919.606.1337
Fax: 919.573.9423
Page 1
Page 2
Summary
• NCMD mission and vision • Why focus on medical devices?
• North Carolina’s assets • Defining the NCMD space • Target Cluster • Services • Board of Directors • Event Outlook
Page 3
NCMD Mission & Vision
• Mission: Position North Carolina’s medical device and diagnostic industry as a research, development, and production world leader • Vision: Enhance North Carolina’s medical device and diagnostic industry through public policy, networking, training, and business development
Why focus on medical devices?
• NC consistently in top
3-5 states for Biotech
, yet not positioned in the medical device market •
$94 billion market
growing at 7% per year • Creates
high paying jobs
– both in research for areas like RTP and in manufacturing in the more rural parts of the state • According to economic census data, there are currently
15,000
medical device related jobs in NC Page 4
Page 5
Why? (continued)
• Harvard Professor Michael Porter Medical devices are an “under-realized opportunity” for North Carolina • RTI International “Identify and task an organization to serve a professional catalyst role by inventorying medical device and diagnostics capabilities and needs, conducting networking events, and addressing industry needs.”
North Carolina’s Assets
• 246 medical equipment manufacturing facilities • Commitment to employer training in Bioscience by investing in programs at many community colleges • 4 world class medical schools (UNC, ECU, Duke, & Wake Forest) • 4 Biomedical Engineering programs (UNC, NCSU, Duke, & Wake Forest) • 1 of only 27 US veterinary schools (NCSU) • Leading biology experts and growing Medical Physics program (UNCC) • Growing Biomedical Engineering group (ECU) • Triangle region second only to Boston in NIH funding for medical schools
Medical Equipment Manufacturing Facilities Map prepared by the NC Dept. of Commerce Div. of Policy, Research & Strategic Planning Source: Harris InfoSource referenced August 2004
•
Legend Manufacturing Locations
Page 6
Defining the NCMD space:
…intended to affect the structure or any function of the body… Page 7 • • • • • Pharmaceutical/Drugs – Manufactured by a chemical process • Biotechnology/Biologics – Manufactured by a biological process
Medical Devices
– Mechanical, Electrical, etc.
– Neither chemical nor biological mfg. process
Combination Products
– Two or Three of the above combined/kitted –
Forecast to be a $9.5 billion market by 2009 Diagnostic Products Medical Information Systems
Target Cluster
• Research/Develop/Manufacture Medical: – Devices, combo products, diagnostics, and info systems – Platform technology for above product types • Suppliers and Service Companies – Including Contract Manufacturers • Hospitals and Clinics – Individual Clinicians – Individual Departments (such as Sports Medicine) • Academic Institutions – Individual Researchers – Departments (such as Biomedical Engineering Programs) • Any interested individual or organization Page 8
NCMD Services
• Host
Training programs & forums
with expert speakers discussing relevant topics and to promote networking • • Assemble a statewide
device & diagnostic directory Advocate for policy
to create best environment for existing & new companies, and for recruitment to NC • • Hold an
annual conference
for the state, bringing together and showcasing NC’s medical device industry • Maintain a
job board
to assist in searches for NC device & diagnostic companies
Maximize intra-state business
among existing companies to help create more jobs Page 9
• • • • • • • • • • • • • •
Board of Directors
Rich West
, Adigy CEO - NCMD Chairman and executive committee member
Peyton Anderson
, Affinergy CEO - NCMD Chair-elect & executive committee member
Sam Taylor
, Exec. VP, NCBIO - NCMD Finance Chair & executive committee member
Jeff Clark
, Managing General Partner, The Aurora Funds
Monica Doss
, President, CED - NCMD executive committee member
Geff Erickson
, Ph.D., Sr. Associate, A.M. Pappas & Associates - NCMD executive committee member
Richard Kindberg
, Sr. VP & General Manager, Medical Products Div., Teleflex Medical
Garheng Kong
, M.D., Ph.D., Partner, Intersouth Partners
Dayn McBee
, SunTech Medical CEO
Neil C. Olson
, D.V.M., Ph.D., NC State University - NCMD executive committee member
Dan Pelak
, President and CEO, Closure Medical
Bob Singletary
, Exec. Director, Research & Technology, WakeMed Health and Hospitals
Sam Tetlow
, Principal, Research Triangle Ventures
Rob Tyler
, Partner, Hutchison+Mason PLLC - NCMD executive committee member Page 10
Event Outlook
• 5/16/05 – NCMD Regulatory Forum – Patricia Love, Associate Director, FDA, Office of Combination Products – Heather Rosecrans, Director of the Premarket Notification (510(k)) Staff, FDA, Office of Device Evaluation • Aug/Sept ’05 – NC MedTech Outlook (Charlotte?) • November ’05 – ½ day device day conference • February ’06 – NCMD Meet new companies and venture forum (Winston-Salem?) Page 11